SF
Stokes Frank
Chief Financial Officer
OtherM
Insider track record
CFONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Stokes Frank, Chief Financial Officer. Insider active across 1 company, notably Castle Biosciences INC. In total, 21 disclosures have been published. Split: 0 buy · 8 sells. Total volume traded: €1.7m. History available since 15 June 2021. The latest transaction was disclosed on 14 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Stokes Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
24,908 shares@ US$29.77Common StockSEC:0001628280-26-057644:0
6,001 shares@ US$27.9813.0% of flowCommon StockSEC:0001628280-26-016019:0
5,300 shares@ US$27.3211.2% of flowCommon StockSEC:0001628280-26-015334:0
8,124 shares0Common StockSEC:0001782815-26-000002:0
4,496 shares@ US$37.4517.1% of flowCommon StockSEC:0001628280-25-057013:0
14,616 sharesCommon StockSEC:0001628280-25-056627:0
5,388 shares@ US$35.0823.4% of flowCommon StockSEC:0001628280-25-052021:0
9,744 shares0Common StockSEC:0001782815-25-000003:0
12,186 sharesCommon StockSEC:0001447362-25-000034:0
8,046 shares@ US$26.7037.0% of flowCommon StockSEC:0001447362-25-000019:0
14,617 sharesCommon StockSEC:0001447362-24-000196:0
6,123 shares@ US$29.8731.2% of flowCommon StockSEC:0001447362-24-000187:0
4,600 shares@ US$25.19719.0% of flowCommon StockSEC:0001447362-24-000129:0
9,745 shares0Common StockSEC:0001447362-24-000130:0
14,617 sharesCommon StockSEC:0001447362-23-000177:0
4,000 shares@ US$3.382.2% of flowCommon StockSEC:0001447362-23-000056:0
2,000 sharesCommon StockSEC:0001447362-22-000196:0
4,000 shares@ US$3.381.2% of flowCommon StockSEC:0001447362-22-000089:0
1,114 sharesCommon StockSEC:0001447362-22-000072:0
2,000 sharesCommon StockSEC:0001447362-21-000272:0
11,600 shares@ US$2.392.1% of flowCommon StockSEC:0001447362-21-000148:0
About Stokes Frank
Stokes Frank is Directeur Financier and Chief Financial Officer at Castle Biosciences INC (XNAS). He has 20 filings in total, and across the sampled recent filings they span from 2021-06-17 to 2026-03-09, with EUR 0 of buys and EUR 1,061,429 of sells, the most frequent transaction nature being Levée d'options.